• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure.

作者信息

Millenaar Dominic, Böhm Michael

机构信息

Department of Internal Medicine III, Cardiology, Angiology and Intensive Care Medicine, Saarland University Hospital, Kirrberger Str. 1, IMED, building 41, 66421 Homburg/Saar, Germany.

出版信息

Eur Heart J. 2020 Dec 21;41(48):4600. doi: 10.1093/eurheartj/ehaa774.

DOI:10.1093/eurheartj/ehaa774
PMID:33167035
Abstract
摘要

相似文献

1
Atrial fibrillation: selecting patients at risk for cardiovascular events by blood pressure.
Eur Heart J. 2020 Dec 21;41(48):4600. doi: 10.1093/eurheartj/ehaa774.
2
Atrial fibrillation, an equivalent of cardiovascular disease risk.心房颤动，等同于心血管疾病风险。
Eur Heart J. 2020 Dec 21;41(48):4599. doi: 10.1093/eurheartj/ehaa771.
3
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.达比加群、利伐沙班和华法林导致胃肠道出血的比较风险：基于人群的队列研究。
BMJ. 2015 Apr 24;350:h1857. doi: 10.1136/bmj.h1857.
4
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.利伐沙班与达比加群或华法林在心房颤动卒中预防真实世界研究中的比较：系统评价和荟萃分析
Stroke. 2017 Apr;48(4):970-976. doi: 10.1161/STROKEAHA.116.016275. Epub 2017 Feb 17.
5
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.达比加群与华法林相比用于心脏复律及不良事件风险的全国性队列研究
PLoS One. 2015 Oct 29;10(10):e0141377. doi: 10.1371/journal.pone.0141377. eCollection 2015.
6
Oral anticoagulants usage in Japanese patients aged 18-74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data.基于保险理赔数据的 18-74 岁非瓣膜性心房颤动日本患者的口服抗凝药物使用情况：一项回顾性分析。
Fam Pract. 2019 Nov 18;36(6):685-692. doi: 10.1093/fampra/cmz016.
7
Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.达比加群酯与维生素K拮抗剂预防心房颤动患者卒中的成本效益分析：法国医保支付方视角
Arch Cardiovasc Dis. 2014 Jun-Jul;107(6-7):381-90. doi: 10.1016/j.acvd.2014.04.009. Epub 2014 Jun 24.
8
Blood pressure targets in atrial fibrillation.
Eur Heart J. 2020 Aug 7;41(30):2860-2862. doi: 10.1093/eurheartj/ehaa319.
9
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?华法林预防卒中血栓栓塞是否能预防房颤患者的 MI？
Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23.
10
Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.老年 Medicare 患者在非瓣膜性心房颤动中接受达比加群或华法林治疗的心血管、出血和死亡率风险。
Circulation. 2015 Jan 13;131(2):157-64. doi: 10.1161/CIRCULATIONAHA.114.012061. Epub 2014 Oct 30.